ClinicalTrials.Veeva

Menu

Could a Preoperative Feeding Jejunostomy Decrease Sarcopenia for Patients With Oesogastric Adenocarcinoma ?

U

University Hospital, Strasbourg, France

Status

Unknown

Conditions

Sarcopenia

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The study of sarcopenia is a subject that is the subject of numerous research and publications, particularly because of its link with a poor prognosis for many cancers.

In an article published by the digestive surgery team, the role of feeding jejunostomy has been demonstrated: it allowed more patients to reach the 2nd stage of surgery and a better tolerance of chemotherapy.

Investigators wanted to study retrospectively the impact of feeding jejunostomy on radiological sarcopenia. Is the positive effect of jejunostomy in gastric cancers associated with a decrease in sarcopenia?

Enrollment

40 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Criteria for inclusion:

  • Age 18-80 years
  • Sex: H or F
  • Subject giving their consent for their participation
  • Gastric cancers
  • stage> IB
  • whether or not a feeding jejunostomy
  • CT scan performed at the HUS, after the end of the courses of chemotherapy and / or before the surgery.

Exclusion criteria:

  • antecedent level L3 surgery,
  • psoas hematoma
  • No CT performed at HUS at the end of chemotherapy and / or before surgery
  • Impossibility of giving the subject informed information
  • Subject under the protection of justice
  • Subject under guardianship or curatorship

Trial contacts and locations

1

Loading...

Central trial contact

Francis VEILLON, MD, PhD; Aïna VENKATASAMY, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems